Gaush Meditech Ltd (FRA:F7Y)
Germany
· Delayed Price · Currency is EUR 0.5950
-0.0300 (-4.80%)
At close: Apr 25, 2025, 10:00 PM CET
Gaush Meditech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 1,428 | 1,406 | 1,254 | 1,298 | 962.08 | Upgrade
|
| Revenue Growth (YoY) | 1.58% | 12.16% | -3.42% | 34.94% | -13.06% | Upgrade
|
| Cost of Revenue | 765.01 | 721.64 | 632.54 | 696.61 | 525.91 | Upgrade
|
| Gross Profit | 663.39 | 684.6 | 621.25 | 601.61 | 436.17 | Upgrade
|
| Selling, General & Admin | 378.36 | 378.21 | 333.94 | 320.99 | 250.9 | Upgrade
|
| Research & Development | 78.42 | 52.88 | 41.09 | 23.51 | 3.14 | Upgrade
|
| Other Operating Expenses | 12.06 | 0.2 | 19.19 | 13.8 | 1.57 | Upgrade
|
| Operating Expenses | 468.84 | 431.3 | 394.21 | 358.3 | 255.61 | Upgrade
|
| Operating Income | 194.55 | 253.3 | 227.03 | 243.32 | 180.56 | Upgrade
|
| Interest Expense | -36.71 | -50.61 | -42.68 | -83.53 | -3.08 | Upgrade
|
| Interest & Investment Income | 3.18 | 6.58 | 4.68 | 2.02 | 3.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -5.71 | 15.56 | -172.47 | 61.82 | 18.32 | Upgrade
|
| Other Non Operating Income (Expenses) | 19.52 | 18.8 | 16.43 | 13.97 | 12.73 | Upgrade
|
| EBT Excluding Unusual Items | 174.82 | 243.63 | 32.99 | 237.6 | 211.66 | Upgrade
|
| Impairment of Goodwill | -23.26 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.72 | 3.96 | -307.42 | -375.51 | -62.36 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.15 | -0.67 | -0.05 | -0.14 | Upgrade
|
| Pretax Income | 155.29 | 247.74 | -275.09 | -137.96 | 149.16 | Upgrade
|
| Income Tax Expense | 66.76 | 74.82 | 77.62 | 53.61 | 50.62 | Upgrade
|
| Earnings From Continuing Operations | 88.52 | 172.91 | -352.71 | -191.57 | 98.54 | Upgrade
|
| Minority Interest in Earnings | 3.87 | 0.61 | 3.09 | 1.12 | 0.83 | Upgrade
|
| Net Income | 92.39 | 173.52 | -349.62 | -190.45 | 99.37 | Upgrade
|
| Net Income to Common | 92.39 | 173.52 | -349.62 | -190.45 | 99.37 | Upgrade
|
| Net Income Growth | -46.75% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 148 | 148 | 97 | 96 | 105 | Upgrade
|
| Shares Outstanding (Diluted) | 148 | 148 | 97 | 96 | 105 | Upgrade
|
| Shares Change (YoY) | -0.14% | 52.69% | 1.16% | -9.03% | -3.28% | Upgrade
|
| EPS (Basic) | 0.63 | 1.17 | -3.61 | -1.99 | 0.94 | Upgrade
|
| EPS (Diluted) | 0.63 | 1.17 | -3.61 | -1.99 | 0.94 | Upgrade
|
| EPS Growth | -46.68% | - | - | - | - | Upgrade
|
| Free Cash Flow | - | 214.11 | 189.03 | 137.94 | 128.23 | Upgrade
|
| Free Cash Flow Per Share | - | 1.45 | 1.95 | 1.44 | 1.22 | Upgrade
|
| Dividend Per Share | 0.282 | 0.998 | - | - | - | Upgrade
|
| Dividend Growth | -71.77% | - | - | - | - | Upgrade
|
| Gross Margin | 46.44% | 48.68% | 49.55% | 46.34% | 45.34% | Upgrade
|
| Operating Margin | 13.62% | 18.01% | 18.11% | 18.74% | 18.77% | Upgrade
|
| Profit Margin | 6.47% | 12.34% | -27.88% | -14.67% | 10.33% | Upgrade
|
| Free Cash Flow Margin | - | 15.23% | 15.08% | 10.63% | 13.33% | Upgrade
|
| EBITDA | 247.31 | 306.06 | 271.91 | 287.2 | 185.27 | Upgrade
|
| EBITDA Margin | 17.31% | 21.77% | 21.69% | 22.12% | 19.26% | Upgrade
|
| D&A For EBITDA | 52.76 | 52.76 | 44.87 | 43.88 | 4.71 | Upgrade
|
| EBIT | 194.55 | 253.3 | 227.03 | 243.32 | 180.56 | Upgrade
|
| EBIT Margin | 13.62% | 18.01% | 18.11% | 18.74% | 18.77% | Upgrade
|
| Effective Tax Rate | 42.99% | 30.20% | - | - | 33.94% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.